30 results
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... CongestiveHeartFailure #Systolic #HFrEF ... #Algorithm #Management ... #Cardiology #ivabradine ... #Medications
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
/diagnosis and treatment ... , haemoglobin; HFrEF ... Iron #Deficiency #Management ... #HeartFailure #Cardiology ... #Indications #Treatment
Immediate Treatment for Myocardial infraction
#management #pharmacology #medications #treatment #cardiology #mnemonic
Immediate Treatment ... Myocardial infraction #management ... #pharmacology # ... medications #treatment ... #cardiology #mnemonic
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
) Treatment - GDMT ... getting patients on medication ... #Pharmacology # ... Management #Treatment ... #StageC #Cardiology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications ... #decisionaid #cardiology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #management #pharmacology ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Trypanosomiasis #IDSA ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... candida #mucosal #IDSA ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology